Paper
Document
Download
Flag content
0

Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

Save
TipTip
Document
Download
Flag content
0
TipTip
Save
Document
Download
Flag content